SCHEMBL31583802

SCHEMBL31583802

CCOC(=O)C1(C#N)Cc2cc(Cl)c(Cl)cc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
OPRM1 P35372 3/20 0.42
SLC6A4 P31645 3/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A3 Q01959 2/20 0.37
MAPT P10636 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
GPR35 Q9HC97 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 1/20 0.35
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
BRD4 O60885 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10924592 0.85 KDM4E (0.43) ESR1ESR2MAPTMEN1KMT2A
SCHEMBL10708179 0.84 ESR1 (0.44) ESR1ESR2OPRM1SLC6A4MAPT
SCHEMBL6183360 0.82 BRD4 (0.48) ESR1ESR2OPRM1SLC6A4MAPT
SCHEMBL21326790 0.80 ESR1 (0.44) ESR1ESR2MAPTMEN1KMT2A
SCHEMBL16595177 0.80 OPRM1 (0.47) ESR1ESR2OPRM1SLC6A4SLC6A2
SCHEMBL13328476 0.77 OPRM1 (0.45) OPRM1SLC6A4SLC6A2SLC6A3MAPT
SCHEMBL31583729 0.76 TTR (0.31) OPRM1TSHR
Hydrochloric Acid SCHEMBL4835381 0.76 OPRM1 (0.47) OPRM1SLC6A4SLC6A2SLC6A3MAPT
SCHEMBL102472 0.73 POLB (0.41) OPRM1SLC6A4MEN1KMT2ASMN1; SMN2
SCHEMBL13887043 0.73 ALDH1A1 (0.36) ESR1ESR2OPRM1SLC6A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106910-A1 DEGRADER MOLECULES TARGETING ANDROGEN RECEPTOR FLARE THERAPEUTICS INC. (US) 2025-05-22 WO disclosed